Vimarsana
Biggest News Aggregation in the World

Ebubechukwu Ezeh News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Ebubechukwu Ezeh. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Ebubechukwu Ezeh Today - Breaking & Trending Today

Trans adults in rural areas at higher risk of cardiovascular disease - Vimarsana News

Trans adults in rural areas at higher risk of cardiovascular disease

“The physical risks are likely heightened by the mental stress that many LGBTQ+ people encounter due to discrimination.

Transgender adults in rural US had disproport - Vimarsana News

Transgender adults in rural US had disproport

In a small study of adults living in rural America, those who identified as transgender were more likely to have cardiovascular disease risk factors, including tobacco use, obesity, high blood pressure, Type 2 diabetes or insulin resistance, high cholesterol and/or alcohol use.

Transgender adults in rural US more likely to have cardiovascular disease risk factors - Vimarsana News

Transgender adults in rural US more likely to have cardiovascular disease risk factors

Transgender adults living in the rural Appalachian area of the U.S., were more likely to have cardiovascular disease risk factors, like tobacco use, obesity and high blood pressure, thank their cisgender peers, according to a preliminary study to be presented at the American Heart Association's Scientific Sessions 2023.

Guidance for Managing Pain in Patients with Cancer and OUD - Vimarsana News

Guidance for Managing Pain in Patients with Cancer and OUD

Strategies gleaned from palliative care, addiction specialist consensus Patient prognosis was the cornerstone of a consensus statement on strategies for managing cancer pain in people with advanced disease and opioid use disorder (OUD). Based on qualitative data from experts, gathered via an online modified Delphi process, the following recommendations were developed: For a patient with